BioNTech SE - ADR

NASDAQ:BNTX   4:00:00 PM EDT
92.25
-0.72 (-0.77%)
5:53:52 PM EDT: $93.30 +1.05 (+1.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)21.93B
Current PE23.57
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$538.84 Million
Adjusted EPS-$0.95
See more estimates
10-Day MA$92.41
50-Day MA$93.53
200-Day MA$102.92
See more pivots

BioNTech SE - ADR Stock, NASDAQ:BNTX

An der Goldgrube 12, Mainz, Rheinland-Pfalz 55131
Germany
Phone: +49.6131.9084.0
Number of Employees: 3082

Description

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.